Symptomatic improvement in gastroesophageal reflux disease (GERD) following laparoscopic Roux-en-Y gastric bypass

Keyphrases

• Gastroesophageal Reflux Disease 100%
• Laparoscopic Roux-en-Y Gastric Bypass (LRYGB) 100%
• Symptomatic Improvement 100%
• Morbidly Obese Patients 42%
• Disease Symptoms 28%
• Patient Satisfaction 28%
• Physical Function 14%
• Medication Use 14%
• Wheezing 14%
• Morbid Obesity 14%
• Body Mass Index 14%
• After Surgery 14%
• Short Form 36 (SF-36) 14%
• Mental Component Summary Scores 14%
• Excess Weight Loss 14%
• Function Score 14%
• Fundoplication 14%
• Heartburn 14%
• H2 Blockers 14%
• Mean Excess Function 14%
• Proton Pump Inhibitors 14%
• Symptomatic Control 14%
• Quality of Life Satisfaction 14%
• As(III) 14%
• Laryngitis 14%
• Massive Weight Loss 14%
• Good Control 14%

Nursing and Health Professions

• Roux-en-Y Gastric Bypass 100%
• Gastroesophageal Reflux 100%
• Patient Satisfaction 28%
• Quality of Life 14%
• Body Mass 14%
• Wheezing 14%
• Histamine H2 Receptor Antagonist 14%
• Proton Pump Inhibitor 14%
• Stomach Fundoplication 14%
• Short Form 36 14%
• Morbid Obesity 14%
• Laryngitis 14%
• Heartburn 14%

Medicine and Dentistry

• Gastroesophageal Reflux 100%
• Roux-en-Y Gastric Bypass 100%
• Patient Satisfaction 28%
• Quality of Life 14%
• Morbid Obesity 14%
• Body Mass Index 14%
• Short Form 36 14%
• Nissen Fundoplication 14%
• Wheeze 14%
• Proton-Pump Inhibitor 14%
• H2 Antagonist 14%
• Heartburn 14%
• Laryngitis 14%